分子和临床风险因素与肌肉纤维化患者的血栓和出血有关
Olga Morath1, Carl Crodel1, Jenny Rinke1
1Klinik für Innere Medizin II, Abteilung Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany.
Hamostaseologie
|December 21, 2024
概括
JAK2-V617F突变和先前的血栓形成增加了髓纤维化 (MF) 中静脉血栓栓塞 (VTE) 的风险. 患有前纤维性MF的患者面临更高的动脉血栓事件 (ATE) 风险.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 血栓形成研究研究
背景情况:
- 骨髓纤维化 (MF) 具有巨大的血栓形成和出血的风险,但往往被低估.
- 研究分子和临床因素对于管理这些并发症至关重要.
研究的目的:
- 确定肌纤维化 (MF) 中静脉 (VTE) 和动脉 (ATE) 血栓事件的分子和临床风险因素.
- 评估MF患者出血发作相关的风险因素.
主要方法:
- 分析了246名连续多发性肺炎患者的数据.
- 在191名患者中进行驱动器突变测试 (JAK2,CALR,MPL).
主要成果:
- 在61.8%的患者中发现JAK2-V617F突变;在26.2%的患者中发现CALR;在3.1%的患者中发现MPL.
- JAK2-V617F突变 (OR: 2.5) 和之前的VTE (OR: 7.6) 显著增加了VTE风险.
- 前纤维性MF患者的ATE率高于MF患者的ATE率.
- 3级纤维化与出血风险增加有关 (OR:3.4).
结论:
- JAK2-V617F突变和先前的血栓形成是MF中VTE的强有力的预测因素.
- 患有前纤维性MF的患者应被认为具有高ATE风险.
相关概念视频
Disorders of Hemostasis
699
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
699
Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Clot Retraction and Fibrinolysis
3.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.8K


